Skip to content
10-K

Annual Report

Celularity Inc. CELU CELUW

0001493152-26-020424

← back to feed
Filed
Apr 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 28, 2026 28.95M sh
Shares Diluted FY 2025 · Dec 31, 2025 25.6M sh
Shares Diluted FY 2025 · Dec 31, 2024 21.89M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$13.25M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$6.4M
Cash And Equivalents FY 2025 · Dec 31, 2025 $6.18M
Cash And Equivalents FY 2025 · Dec 31, 2024 $738K
Stockholders Equity FY 2025 · Dec 31, 2025 −$38.06M
Stockholders Equity FY 2025 · Dec 31, 2024 $8.84M
Stockholders Equity FY 2025 · Dec 31, 2023 $40.96M
Current Liabilities FY 2025 · Dec 31, 2025 $80.76M
Current Liabilities FY 2025 · Dec 31, 2024 $53.68M
Total Liabilities FY 2025 · Dec 31, 2025 $145.39M
Total Liabilities FY 2025 · Dec 31, 2024 $123.85M
Current Assets FY 2025 · Dec 31, 2025 $12.32M
Current Assets FY 2025 · Dec 31, 2024 $20.56M
Total Assets FY 2025 · Dec 31, 2025 $107.33M
Total Assets FY 2025 · Dec 31, 2024 $132.68M
Eps Diluted FY 2025 · Dec 31, 2025 −$3.59
Eps Diluted FY 2025 · Dec 31, 2024 −$2.64
Eps Basic FY 2025 · Dec 31, 2025 −$3.59
Eps Basic FY 2025 · Dec 31, 2024 −$2.64
Sga Expense FY 2025 · Dec 31, 2025 $51.27M
Sga Expense FY 2025 · Dec 31, 2024 $58.64M
Rd Expense FY 2025 · Dec 31, 2025 $15.03M
Rd Expense FY 2025 · Dec 31, 2024 $17.39M
Net Income FY 2025 · Dec 31, 2025 −$91.72M
Net Income FY 2025 · Dec 31, 2024 −$57.89M
Operating Income FY 2025 · Dec 31, 2025 −$61.31M
Operating Income FY 2025 · Dec 31, 2024 −$38.36M
Cost Of Revenue FY 2025 · Dec 31, 2025 $20.07M
Cost Of Revenue FY 2025 · Dec 31, 2024 $14.99M
Revenue FY 2025 · Dec 31, 2025 $26.55M
Revenue FY 2025 · Dec 31, 2024 $54.22M
Capex FY 2025 · Dec 31, 2024 $161K